 |
Molecular Oncology is published by Elsevier on behalf of the Federation of European Biochemical Societies
Free access to selected content, news items related to Molecular Oncology, free special issues and other pertinent journal information
can be found at the Molecular Oncology website:  http://www.molecularoncology.org
Editor in Chief:
J. Celis
See editorial board for all editors information
Description
Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven
translational research. Topics include:
• Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and
metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response.
• Emerging technologies
(genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems.
•Biomarkers: diagnosis,
prognosis, stratification and efficacy.
• Cancer genetics, epigenetics, and genomic instability.
• Minimal residual
disease, pre-malignant lesions.
• Cancer micro-environment.
• Molecular pathology.
• Tumour immunology.
• Translational research.
• Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance,
and individualised treatment).
• Chemotherapy, radiotherapy and surgery.
• Clinical pharmacology.
• Clinical
trials, integration of basic science into cancer clinical trials.
• Epidemiology and prevention.
• Infrastructures
(biobanks, databases, genomic resources).
A main feature of the Journal is to provide an international forum for debating cancer
issues, and for integrating the input of all the stakeholders.
Coverage: Reviews, original articles, technical notes, editorials,
news & views (commentary, science policy issues, ethical and legal issues, patient organisations, industry needs and alliances, regulatory
issues, news items), letters to the editor, conference announcements, advertisements.
Submitting Authors:
Manuscripts can
be submitted to Molecular Oncology at:
http://ees.elsevier.com/molonc/
Bibliographic & ordering information
ISSN: 1574-7891
Imprint: ELSEVIER
Commenced publication 2007
Subscriptions for the year 2009,
Volume 3,
4 issues
Institutional price: Order form
USD 1,014 for all countries except Europe, Japan and Iran
EUR 798 for European countries and Iran
JPY 116,400 for Japan
Conditions of sale & ordering procedures, and links to our regional sales offices.
For an overview of recently-dispatched issues, see the Journal issue
dispatch dates
Audience
Scientists and health professionals interested in molecular aspects of the development, diagnosis and treatment of cancer.
Sponsored
Articles:
Molecular Oncology offers authors the option to sponsor non-subscriber access to their articles on Elsevier's
electronic publishing platforms. For more information please view our Sponsored
Article page.
Institutional online access:
ScienceDirect eSelect
For purchase of online access to this journal on ScienceDirect by credit card.
602/177
Last update: 28 Aug 2008
|
|
| |
